GLENMARK PHARMACEUTICALS, INC., USA

Leading,integrated, research-driven, global pharmaceutical manufacturing company.

Active 2017–2022.

Filings

Filed By

Reported In-House

—

Reported By Firms

$1,070,000

Filings

All 2022 2021 2020 2019 2018 2017

Year	Firm	Period	Amount
2022	KOUNTOUPES DENHAM CARR & REID, LLC	3rd Quarter (July 1 - Sep 30) 3rd Quarter - Termination	$30,000
2022	KOUNTOUPES DENHAM CARR & REID, LLC	2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report	$50,000
2022	KOUNTOUPES DENHAM CARR & REID, LLC	1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report	$50,000
2021	KOUNTOUPES DENHAM CARR & REID, LLC	4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report	$50,000
2021	KOUNTOUPES DENHAM CARR & REID, LLC	3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report	$50,000
2021	KOUNTOUPES DENHAM CARR & REID, LLC	2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report	$50,000
2021	KOUNTOUPES DENHAM CARR & REID, LLC	1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report	$50,000
2020	KOUNTOUPES DENHAM CARR & REID, LLC	4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report	$50,000
2020	KOUNTOUPES DENHAM CARR & REID, LLC	3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report	$50,000
2020	KOUNTOUPES DENHAM CARR & REID, LLC	2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report	$50,000

Page 1 of 3 · 25 filings Next

Filed By

Firm	Filings	Amount
KOUNTOUPES DENHAM CARR & REID, LLC	25	$1,070,000

Issue Areas

Issue	Activities
Health Issues	25
Pharmacy	23
Medicare/Medicaid	18
Copyright/Patent/Trademark	9
Taxation/Internal Revenue Code	3

H.R. 748 H. R. 938 H.R. 6800 H. R. 1499 H.R. 2853 H.R. 1319 H.R. 5376 S.1895 H. R. 2430 S. 934 H. R. 1628 H.R. 133 H. R. 3 H.R. 938